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Summary: A specific radioimmunoassay of llß4iydroxy-4-androstene-3,17-dione, an androgen of exclusively
adrenal origin, is described and evaluated. The antiserum was raised in rabbits using 6ß,llß-dihydroxy-4-
androstene-3,17-dione-6ß-hemisuccinate:bovine serumalbumin conjugate äs an immunogen. The method has
been used for determination of the plasma levels of the hormone in healthy subjects, including children, with
regard to the possibility its use äs a laboratory marker for monitoring corticoid therapy in patients with
congenital adrenal hyperplasia and in patients with various endocrine disorders, under basal conditions and
after dynamic tests. The plasma levels of llß-hydroxyandrostenedione (means ± s.d.) in healthy persons at
8 a. m. were 8.69 ± 2.88 (men), 7.72 ± 2.85 (women), 8.73 ± 5.13 (boys) and 7.88 ± 5.23 (girls) nmol/L
respectively. The hormone cöncentrations followed the pattern of circadian rhythm of Cortisol, they were
increased markedly after cprticotropin and suppressed by dexamethasone.
t*. - sone, and its pattern of production is independent of
the menstrual cycle in women (2, 3). It originales
llß-Hydroxy-4-androstene-3,17-dione (llß-hydroxy- frorn adrenal 11 ß-hydroxylation of androstenedione
androstenedione) is believed to be an androgen of rather than from side chain cleavage of Cortisol (4).
exclusively adrenal origin, measurement of which In the study of its dynamics, its metabolic clearance
could serve äs an indicator of adrenal contribution rate, the main distribution volumes and both blood
to an overall androgen production (1—3). This is levels and urinary secretion rates were determined (5).
sustained by the observations that llß^hydroxyan- Values close to those of its precursor androstenedione
drostenedione levels follow the circadian rhythm of were obtained, the blood production rate being how-
cortisol, its production is stimulated by both cortico- ever lower than that of androstenedione, in agree-
tropin and corticoliberin but not by human chorionic ment with the fact that a portion of the latter origi-
gonadotropin and supresses markedly by dexametha- nates from the gonads.
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In this paper a radioimmunoassay is described, using
a highly specific antiserum raised with an imrnunogen
prepared by a more effective technique than pre-
viously reported (4). The method has been used for
determination of 11 -hydroxyandrostenedione in
healthy subjects, including children (with a special
regard to the possibility of laboratory monitoring
of glucocorticoid therapy of children suffering from





radioactivity 3.81 TBq (103 Ci)/mmol, was prepared by sodium
bismuthate oxidation of [3H]cortisol (Radiochemical Centre,
Amersham, U. K.) (6) s follows: To a solution of pH]cortisol
(3.7 MBq = 100 μΟ), dissolved in l ml of 50% acetic acid,
0.5 g of sodium bismuthate was added and mixed by a magnetic
stirrer for 30 min. The solid was removed by centrifugation,
washed repeatedly with acetic acid and following centrifugation
the collected supernatants were diluted with water (2 ml). Ap-
proximately 10 mg of sodium metabisulphite was then added
and the mixture was extracted with dichloromethane. The or-
ganic extract was washed with 0.1 mol/1 sodium hydroxide and
water, dried over sodium sulphate and after evaporation of
the solvent, chromatographed on DC-Alufolien Kieselgel 60/
Kieselgur F-254 (Merck, F. R. G.) in the System dichlorome-
thane — methanol 97 + 3 (by vol.) together with an authentic
11 -hydroxyandrostenedione. The radioactivity corresponding
to the Standard (Rf = 0.25) was detected by scanning, then
eluted with ethanol. The yields of the product depended on the
purity of the starting [3H]cortisol and averaged usually 60 —
80%.
Non-radioactive steroids were from Koch and Light (U. K.) or
Steraloids (Pawling, USA). High-purity Standard 11 -hydroxy-
androstenedione was kindly supplied by M. R. C. (U. K.). Se-
phadex G-25 and Dextran T-70 were from Pharmacia (Sweden),
active charcoal (Norit A) from Serva (F. R. G.). The scintilla-
tion fluid contained 4 g PPO, 50 mg POPOP (Koch + Light)
and 20 ml of methanol in l liter of toluene. All other chemicals
and solvents were of Czechoslovak origin, analytical grade.
Diethyl ether for extraction was freed of peroxides and distilled.
Synthesis of the immunogen
6 ,l l -Dihydroxy-4-androstene-3,l 7-dione 6 -hemisuccinate
was prepared from cortisol by a novel high-yield photochemical
6 -hydroxylation procedure of Kasal & Smolikov (7). It was
attached to bovine serum albumin by the mixed-anhydride
method of Erlanger et al. (8) and purified by Sephadex G-25
gel filtration. The steroid/albumin ratio, assessed from the
difference of absorbancies at 254 nm of equimolar Solutions of
the product and albumin was 18.
Cross-reactions of steroids with the antisera were estimated by
the 50% displacement method (10) under conditions of the
assay. The apparent intrinsic association constants were deter-
mined at three different temperatures (4, 24 and 37 °C) by a
modified (11) Scatchard analysis of the Standard curves. From
the data obtained, the changes of thermodynamic parameters,
i. e. the reaction enthalpy and entropy, were calculated accord-
ing to Walker & Keane (12).
Sample preparation and radioimmunoassay
Plasma (100 μΐ) was extracted with diethyl ether (2ml) and
aliquots of the extracts (200 μΐ corresponding to 10 μΐ of
plasma) in duplicate were evaporated to dryness in the assay
tubes; the residue from this evaporation was processed directly
by radioimmunoassay. The extraction recovery of added tracer
averaged 96% and thus no correction for extraction losses
was made. Extracts of pooled plasma, stripped of endogenous
steroids by repeated treatment with charcoal, were used for the
Standard curve. This contained 0; 1.75; 125 pg/tube of ll -
hydroxyandrostenedione. To each tube (unknown samples and
Standards) [3H]11 -hydroxyandrostenedione (335 Bq = 10000
dp. min"1) and antiserum (100 μΐ each) in the assay buffer were
added and the volume was adjusted to 0.5 ml with the buffer.
Sodium phosphate 0.05 mol/1, pH 7.4, containing bovine serum-
albumin (l g/l) and sodium Chloride (4.5 g/l) was used. After
incubation at 4 °C overnight, a charcoal-dextran Suspension
(2.5 g/l Norit A, 0.25 g/l Dextran T-70, 500 μΐ) was added. The
tubes were mixed briefly by vortexing, incubated for 20 min in
an ice bath, then centrifuged at 1500 g for 10 min in a refriger-
ated centrifuge. Aliquots of the supernatants (500 μΐ) were
transferred into the scintillation vials containing scintillation
fluid, and after 4 h the radioactivity of tritium was measured
in a Beckman LS-1801 liquid scintillation spectrometer. The
concentrations of 11 -hydroxyandrostenedione were calculated
from the Standard curves in weighed log-logit transformation.
Healthy subjects, patients and performance of dy-
namic tests
The characterization of individual groups of healthy persons
and patients with various endocrine disorders under study is
given in tables 3 and 4.
Dynamic tests were carried out, if medically indicated, in se-
lected groups of patients, s follows. The patients were hospita-
lized at least three days, after which blood was collected for
determination of the basal hormone levels. On the next day at
7 a. m. they received a corticotropin infusion (Synacthen, Ciba,
Switzerland, 0.25 mg in 400 ml of saline), which was repeated
on two successive days. Blood was collected on the third day
at the end of the infusion. After a 3-day pause, they received
dexamethasone (4 χ 0.5 mg a day, for the first two days and
4 χ 2 mg d ring the third and fourth day). Blood was sampled
after the second and fourth day of the test. Finally they were
given a single injection of human chorionic gonadotropin
(Praedyn-Spofa, Czechoslovakia, 3000 I. U. i. m.) plus dexa-
methasone ( 4 x 2 mg), for two days, after which blood was
collected again.
I m m u n i z a t i o n and characterization of antisera
Four female rabbits were immunized with 100 — 200 μg portions
, of the immunogen in l ml of complete Freunds adjuvant-
saline mixture (1 + 1), by multiple intradermal injections on the
dorsal area, at three-weeks intervals (9). The working dilution
of the antiserum used in the radioimmunoassay was l: 20 000.
The antisera were lyophilized and stored at —20 °C.
Determination of other steroid hormones
All hormonal steroids were determined by radioimmunoassay,
using antisera prepared in our laboratories, and tritiated radio-
ligands. The reagents and procedures for determination of
testosterone (13), dehydroepiandrosterone (14), androstene-
dione (15) and cortisol (16) were described previously. 17α-
Hydroxyprogesterone was estimated by the method of Hubl et
al. (17).
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Results
Characterization of the antiserum
Specificity
The specificity of the antiserum used for the radioim-
munoassay in terms of cross-reactions with 16 ste-
roids is shown in table l.
Tab. 1. Cross-reactions of sixteen steroids with the antiserum
to 6ß,l l ß-dihydroxy-4-androstene-3,17-dione-6ß-hemi-
succinate: bovine serum albumin.
Steroid Cross-
reaction





6ß-Hydroxy-4-androstene-3,l 7-dione l .94
3a,l l ß-Dihydroxy-5a-androstan-17-one 0.85
5ß-Androstane-3,l 7-dione 0.71
11 ß,l 7ß-Dihydroxy-4-androsten-3-one 0.70
4-Androstene-3,ll,17-trione 0.58
3ß-Hydroxy-5-androsten-17-one 0.29






Standard curve parameters and thermodynamic char-
acteristics
The characteristics of the Standard curves (specific
binding, 50% intercepts), the apparent intrinsic as-
sociation constants and derived thermodynamic para-
meters (i. e. the reactioii enthalpy and entropy), meas-
ured at three assay temperatures (4, 24 and 37 °C)
are given in table 2.
Tab. 2. Parameters of the Standard curves and derived thermo-
dynamic parameters at three assay temperature.
Tem- Specific 50% K^ ·




















Evaluation of the method
Precision
The intra^-assay coefficient of Variation for a control
sample (coneentration 4.90 nmol/1) was 6.3%
(n = 15); the respective inter-assay coefficient of Vari-
ation was 8.8% (n = 11).
Sensitivity
The least amount of 11 ß-hydroxyandrostenedione
distinguishable from zero at 95% confidence level
was 0.8 pg/tube, corresponding to 0.26 nmol/1.
Accuracy
The average recovery of 20 and 40 pg/tube of llß-
hydroxyandrostenedione added to the above control
sample of plasma was 101%. Statistically undistin-
guishable results were obtained by the analyses of
low, normal and high concentration of 11 ß-hydroxy-
androstenedione (3.94, 5.01 and 9.89 nmol/1), irre-
spective of whether the thin layer Chromatographie
Step (DC-Alufolien developed with dichlorome-
thane — methanol 97 + 3 (by vol.)) was involved. In
the latter case correction for recovery of added tracer
(approximately 34 Bq of the tracer per tube) was
performed.
11 ß-Hydroxyandrostenedione levels in
plasma
Normal subjects
The concentrations of 11 ß-hydroxyandrostenedione
in plasma of healthy men, women and children are
summarized in table 3. A group of young healthy
men (23 — 33 years) with idiopathic oligozoospermia
(sperm count < 20 · 109/1) but without any endocrine
disorder is also included.





























The daily profile of 11 ß-hydroxyandrostenedione and
Cortisol concentrations in a healthy women (32 years)
is shown in figure 1.
Patients with endocrinopathies
The characteristic hormonal parameters (except of
11 ß-hydroxyandrostenedione) of patients under
study and of the control group are given in table 4.
Plasma levels of 11 ß-hydroxyandrostenedione in
these patients under basal conditions and following
stimulatory and suppression tests are shown in
table 5.
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Fig. 1. Diurnal profile of cortisol and 11 ß-hydroxyandrostene-
dione (nmol/1) in a healthy women (32 years). Füll
circles: cortisol, open circles: 11 ß-hydroxyandrostene-
dione.
Children with congenital adrenal hyperplasia
Together with other hormonal steroids (i, e. testoster-
one, dehydroepiandrosterone sulphate, androstene-
dione and 17a-hydroxyprogesterone) 11 ß-hydroxyan-
drostenedione was measured in a group of 37 children
(0.5 — 14 years) with various degrees of congenital
adrenal hyperplasia due to the block of 214iydroxy-
läse. With one exception (l l ß-hydroxyandrostene-
dione concentratipn = 35 nmol/1) they all were under
therapy with corticoids (hydrocortisone + fludrocor-
tisone). The ovef all 11 ß-hydroxyandrostenedione
levels in this group were 12.7 ± 10.2 nmol/1. No
difference was found between adequately and unsuffi-
ciently treated children, äs controlled by clinical fea-
tures, i. e. mineral homeostasis, the degree of bone
maturation corresponding to the chronological age,
and absence of precociöus secondary sexual develop-
ment. 11 ß-^Hydroxyandrostenediorie levels in the for^
mer group (n = 9) averaged 14.4 + 7.2 nmol/1 äs
compared with 12.1 ±11.1 nmol/1 in the latter one
(n =, 27).
Tab. 4. Hormonal characteristics of patients with various endocrine disorders and of controls. Steroid concentrations are in
nmol/1, means + s. d. are given.
Group
Healthy women (follicular phase)
Idiopathic hirsutism
Polycystic ovaries
















































DHEA = unconjugated dehydroepiandrosterone
Tab. 5. llß-Hydroxyandrostenedione levels in patients with various endocrine disorders under basal conditions and following
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Discussion
The llß-hydroxyandrostenedione radioimmunoassay
described here fulfils the common criteria for routine
determination of steroids in body fluids. It uses a
specific antiserum, which distinguishes the measured
hormone from the main potential competitors preseiit
in plasma, such äs androstenedione, testosterone and
their llß-hydroxy- or 11-oxo- substituted analogues.
High cross-reactivity was exhibited only by the 6ß-
hydroxyderivative of the measured Steroid, used for
the synthesis of the immunogen, and by the 5 -
saturated derivative (l l ß-hydroxy-5a-androstane-
3,17-dione), both present in blood in negligible con-
centrations.
The 11 ß-hydroxyandrostenedione levels determinated
in healthy subjects were in agreement with values
reported by others (1 — 3). It should be emphasized
that all measurements were carried out in the morn-
ing, i.e. at the time of the secretory maximum (see
fig. 1). The circadian rhythm of llß-hydroxyandro-
stanedione was almost identical with that of cortisol.
The concentration increase following corticotropin
Stimulation and the marked decrease after dexameth-
asone äs well äs the absence of the response to human
chorionic gonadotropin confirm the previous findings
and provide evidence for the adrenal origin of llß-
hydroxylated androgens (1—3, 18). Thus llß-hy-
droxyandrostendione äs well äs 11 ß-hydroxytestos-
terone may be useful markers of adrenal contribution
in hyperandrogenie states.
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